Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 54,458	$ 40,110
Accounts receivable, net	72,722	69,503
Inventories, net	145,608	145,736
Income taxes receivable	11,541	11,374
Current derivative financial instruments	25,962	22,578
Other current assets	24,795	19,460
Total current assets	335,086	308,761
Property, plant and equipment, net	329,693	329,892
Deferred income tax assets, net	41,082	39,046
Intangibles, net	8,251	12,612
Derivative financial instruments	16,365	14,736
Other noncurrent assets	33,302	35,082
Total assets	763,779	740,129
Current liabilities:
Accounts payable	151,184	120,351
Short-term debt	5,811	7,939
Accrued expenses	67,030	65,731
Income taxes payable	488	1,905
Total current liabilities	224,513	195,926
Long-term debt (less current portion)	481,763	481,449
Noncurrent income tax liabilities	2,916	5,341
Deferred income tax liabilities, net	683	1,105
Other noncurrent liabilities	39,711	43,581
Commitments and contingent liabilities (Note 15)
Mezzanine equity:
Preferred stock, $0.01 par value Authorized - 1,000,000 shares Issued and outstanding - 150,000 shares outstanding at March 31, 2025 and December 31, 2024	302,351	288,465
Noncontrolling redeemable equity	503	480
Shareholders' equity (deficit):
Common stock, $0.01 par value Authorized - 100,000,000 shares Issued and outstanding - 29,474,394 and 28,886,053 shares at March 31, 2025 and December 31, 2024	123,288	123,039
Accumulated other comprehensive income (loss)	(84,343)	(98,471)
Retained earnings (deficit)	(327,606)	(300,786)
Total shareholders' equity (deficit)	(288,661)	(276,218)
Total liabilities, mezzanine equity and shareholders' equity (deficit)	$ 763,779	$ 740,129